ReviewInternational braz j urol : official journal of the Brazilian Society of Urology2020
Bladder Cancer at the time of COVID-19 Outbreak.
Review in International braz j urol : official journal of the Brazilian Society of Urology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04900259 (The Effect of the COVID-19 Pandemic on Primary Bladder Cancer Presentations), which is not on this map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Effect of the COVID-19 Pandemic on Primary Bladder Cancer Presentations
Who cites it
4 citing papers in PubMed.
- Microscopic hematuria and pelvic ultrasonography could rule out flexible cystoscopy during surveillance for T1-low grade non-muscle invasive bladder cancer.Arab journal of urology · 2023Article
- The Impact of COVID-19 Disease on Urology Practice.Surgery journal (New York, N.Y.) · 2021Review
- SARS-COVID-19 transformed the world and urological practice.International braz j urol : official journal of the Brazilian Society of Urology · 2020Article
- Recommendations for prostate cancer diagnosis and treatment during COVID-19 outbreak were not followed in Brazil.International braz j urol : official journal of the Brazilian Society of UrologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 outbreak has led to the deferral of a great number of surgeries in an attempt to reduce transmission of infection, free up hospital beds, intensive care and anaesthetists, and limit aerosol-generating procedures. Guidelines and suggestions have been provided to categorize Urological diseases into risk groups and recommendations are available on procedures that can be or cannot be deferred. We aim to summarise updates on diagnosis, treatment and follow up of bladder cancer during the COVID-19 outbreaks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.